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Abstract
We report a case of 67-year-old man suffering from psoriatic arthritis, type 2 diabetes and diabetic foot syndrome. The patient 
presented symptoms of inflammation of the right ankle joint. Scintigraphic imaging with radiolabeled white blood cells was 
performed to differentiate whether the inflammation was related to psoriatic arthritis or diabetic foot syndrome. After revealing 
that, the inflammatory process was restricted only to the articular space of subtalar joint, the patient was diagnosed with ex-
acerbation of psoriatic arthritis and qualified for radionuclide synovectomy. In patients with coexistent diabetic foot syndrome 
and inflammatory arthritis of the foot it is of vital importance to accurately differentiate these two conditions. We conclude that 
this can be potentially achieved with radiolabeled white blood cells scintigraphic imaging.
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Background
Diabetic foot syndrome (DFS) is a serious complication of 
diabetes mellitus (DM), affecting up to 10% of diabetic patients [1]. 
It could be potentially life-threatening and thus requires quick, accu-
rate diagnosis and immediate treatment. This proves difficulty, since 
various forms of DFS (e.g. osteomyelitis or Charcot foot) have often 
the same initial clinical and radiological symptoms. The problem 
becomes even more challenging with the presence of a coexistent 
rheumatic disease affecting joints of the foot.
Case report
We describe a case of a 67-year-old patient suffering from 
psoriatic arthritis (PsA) for 22 years and type 2 DM complicated by 
Charcot neuroarthropathy for 15 years. The current treatment is oral 
methotrexate 25 mg once a week and intensive insulinotherapy. The 
patient presented symptoms of inflammation of the right ankle joint, 
with swelling, tenderness and pain. In order to differentiate whether 
the clinical symptoms were the manifestation of acute Charcot 
neuroarthropathy or exacerbation of PsA, the patient was referred 
to the nuclear medicine department for scintigraphic evaluation.
The single photon emission computed tomography/ computed 
tomography (SPECT/CT) with technetium-99m labelled white blood 
cells (99mTc-WBC) was performed. The study showed intense radi-
otracer uptake limited to the articular space of the right subtalar joint, 
with physiological 99mTc-WBC distribution in the adjacent talus and 
calcaneus. In the CT scan, massive erosions and degeneration of 
subtalar joint articular surfaces were visible, with no signs of oste-
olysis or destruction of the cancellous bone (Figure 1A).
Based on these findings, inflammatory process involving 
bones was excluded. The patient was diagnosed with psoriatic 
arthritis of the right subtalar joint and subsequently qualified for 
radionuclide synovectomy. Under fluoroscopic guidance, the 
right subtalar joint was punctured from the lateral approach and 
37 MBq (mega Becquerels) of colloidal rhenium-186 sulphide 
were injected. 
Within six months after radiosynovectomy, the clinical symp-
toms of joint inflammation subsided completely. The patient 
reported overall improvement and better life quality. Follow-up scin-
tigraphic imaging with 99mTc-WBC showed physiological distribution 
of the radiotracer, with no signs of active inflammatory process in 
the joints of the right foot (Figure 1B). Plain radiographs of the 
right foot showed marked improvement, with partial resolution of 
bone erosions. Twelve months after radiosynovectomy the patient 
remains symptom-free. 
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To the best of our knowledge this is the first report describing 
a patient with concomitant DFS and inflammatory arthritis of the foot 
successfully diagnosed and treated using radionuclide techniques.
Discussion
Patients with connective tissue diseases have a significantly 
increased risk of diabetes mellitus [2, 3]. Additionally, prolonged 
glucocorticoid therapy in these patients is an independent risk 
factor of developing steroid-induced diabetes. Populations of 
diabetic and rheumatic patients overlap and thus we may expect 
cases with concomitant DFS and arthritis of the foot. In such pa-
tients, initial clinical presentation of different foot conditions may 
be identical, and the results of both plain radiographs and MRI 
may be equivocal [4]. It is crucial to correctly identify the disease 
and start appropriate treatment, since misdiagnosis may have 
catastrophic consequences, e.g. intensifying immunosuppressive 
therapy in a patient with bacterial osteomyelitis. This is especially 
important in PsA where the involvement of the foot structures (en-
thesitis, tenosynovitis, arthritis) is common [5].
Diagnostic modalities of nuclear medicine, especially hybrid 
SPECT/CT imaging with 99mTc-WBC could be a valuable tool for 
diagnosing different inflammatory diseases of the foot. Although 
not specific enough to determine the exact cause of inflammation, 
they can precisely define the extent of the inflammatory process, 
indicating whether the soft tissues, bones or intra-articular space 
are affected. Moreover, SPECT/CT imaging can be used to qualify 
patients for minimally invasive intra-articular procedures like radio-
nuclide synovectomy.
In conclusion, in patients with diabetic foot syndrome and 
coexisting inflammatory joint diseases, hybrid radionuclide imag-
ing techniques might be considered the diagnostic method of 
choice. Further studies are required to determine their sensitivity 
and specificity in this particular clinical setting.
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Figure 1. Initial SPECT/CT of the right foot shows intensive 
accumulation of radiolabeled white blood cells in the subtalar joint (A). 
Six months after radonuclide synovectomy there is only physiological 
distribution of radiolabeled white blood cells in the joints of right foot (B)
